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Abstract  
Objectives: To test the feasibility of implementing a brief but intensive hybrid 
cognitive behaviour therapy (Hybrid CBT) for pain-related insomnia 
Design: Mixed-methods, with qualitative process evaluation on a two-arm 
randomised controlled feasibility trial 
Setting: Primary care 
Participants: Twenty-five adult patients with chronic pain and insomnia 
Intervention:  Hybrid CBT or Self-help control intervention 
Primary and secondary outcome measures: Primary outcomes measures were 
the Insomnia Severity Index and interference scale of the Brief Pain Inventory 
(BPI). Secondary outcomes measures were the present pain intensity rating from 
the BPI, Multidimensional Fatigue Inventory, Hospital Anxiety and Depression 
Scale, and EQ-5D-5L. 
Results: Fourteen participants were randomised to receive Hybrid CBT, 11 to 
receive the self-help control treatment. Of the 14 in the Hybrid CBT group, 9 (64%) 
completed all four treatment sessions (4 discontinued due to poor health; 1 due 
to time constraints). Adherence to the self-help control treatment was not 
monitored. The total number of participants completing the 12-week and 24-
week follow-ups were 12 (6 in each group; Hybrid CBT: 43%; Self-Help: 55%) and 
10 (5 in each group; Hybrid CBT: 36%; Self-help: 45%). Based on the data 
available, candidate outcome measures appeared to be sensitive to changes 
associated with interventions. Thematic analysis of pre-post 
intervention interview data revealed satisfaction with treatment content among 
those who completed the Hybrid CBT whereas those in the Self-help control 
treatment wanted  more contact hours and therapist guidance. Other 
practical suggestions for improvement included shortening the duration of each 
treatment session, reducing the amount of assessment paperwork, and 
minimising the burden of sleep and pain monitoring. 
Conclusion: Important lessons were learnt with regards to the infrastructure 
required to achieve better patient adherence and retention. Based on the 
qualitative feedback provided by a subset of treatment completers, future trials 
should also consider lowering the intensity of treatment and streamlining the data 
collection procedure. 
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Trial registration: ISRCTN 17294365 
 
 
 
Strengths and limitations of this study  
 
 First feasibility trial in the UK to evaluate a new, brief but intensive 
Hybrid CBT for pain-related insomnia compared to self-help control in 
primary care. 
 The Hybrid CBT was manualised, the delivery of which was supported by 
a comprehensive therapist training programme. 
 Patient recruitment was tested in three different health centres of 
different demographic compositions and different socio-economic 
backgrounds.  
 The mixed-methods approach provided both quantitative and qualitative 
information to inform the design and planning of a definitive trial. 
 Rates of attrition and loss to follow-up were high in both arms. 
 
CONSORT Checklist attached  
CORE-Q Checklist attached 
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Introduction 
Chronic pain is a major burden to primary care, accounting for five million GP 
appointments each year in the UK (1, 2). These pain patients usually present with 
multiple symptoms, with insomnia being one of the most common and disruptive 
comorbidities (2-4). In hospital pain clinics, as many as 90% of the patients report 
insomnia of a severity that warrants clinical attention (3, 5-8).  
 
Conventionally sleep disturbance is seen as a secondary symptom to pain, but 
recent research has shown that poor sleep is actually a key driver for persistent 
pain and its associated distress and disability (9-13). Additionally, untreated 
insomnia is a significant risk factor for adverse health outcomes, e.g., 
hypertension, cardiovascular disease, obesity, diabetes, respiratory diseases and 
even increased mortality(14-20).  
 
Although better sleep has long been emphasised by pain patients as an important 
treatment outcome (21, 22), insomnia is rarely a focus in pain management 
programmes. In primary care where most chronic pain patients are managed, 
hypnotics continue to be first-line treatments for insomnia despite the limited 
evidence supporting their long-term efficacy and safety (23). Their prolonged use 
can result in undesirable side effects, increasing the risks of falls, road traffic 
accidents, dementia and mortality in the long term, particularly in older adults 
(24-28). The risks multiply when the effect of polypharmacy is factored in. The 
combined use of benzodiazepines and opioids produce significant respiratory 
depression and is thought to contribute to the recent sharp rise in unintentional 
prescription drug overdose deaths (29).  
 
Psychological interventions offer a promising treatment alternative. The efficacy 
of cognitive behaviour therapy for primary insomnia (CBT-I) has been 
demonstrated by multiple systematic reviews and meta-analyses (30-36). 
However, these treatments are often not available for chronic pain patients 
because of the lack of an empirically-validated treatment protocol adapted and 
tailored for this population (37), a shortage of skilled therapists (38-40), and an 
absence of essential infrastructure for CBT delivery in primary care (28, 30, 41). 
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We have recently evaluated a talking therapy specifically modified for patients 
with pain-related insomnia (42). The intervention simultaneously tackled chronic 
pain and insomnia, combining select components of CBT-I with interventions 
targeting the cognitive-behavioural processes maintaining chronic pain. The 
Hybrid CBT was delivered as an individual therapy over four weeks through 
weekly two-hour sessions. The treatment dosage was eight hours in total, 
approximating the optimal dose recommended for CBT for insomnia disorders 
(43) within a stepped care model (39). In our pilot study with patients recruited 
from hospital pain clinics (i.e., secondary care), the Hybrid CBT was associated 
with greater improvement in sleep at post-treatment compared with a symptom-
monitoring control procedure (treatment effect size of Hybrid CBT: dH = 2.92; 
control: dC = 0.56)(42). Pain intensity did not change (dH = -0.13; dC = 0.14), but 
the Hybrid CBT was associated with greater reductions in pain interference (dH = 
1.92; dC = 1.19), fatigue (dH = 1.81; dC = 0.15) and depression (dH = 0.94; dC = -0.04) 
than control (42). 
 
The current study tested the feasibility of adapting and implementing the Hybrid 
CBT in primary care, using a mixed-methods approach. With a small patient 
sample across three primary care centres from localities with different social-
economic and demographic characteristics, our overarching aim was to generate 
information to inform the development of a definitive randomised controlled trial 
(RCT) for evaluating the clinical outcomes and cost-effectiveness of the Hybrid 
CBT within the UK National Health Service (NHS) setting. The focus of the current 
study was therefore not on detecting differences in outcomes between the Hybrid 
CBT and the control groups, but on evaluating the technical and logistic feasibility 
of a full-scale study. Specifically, our aims were to: (i) check participant’s 
willingness to be randomised between the Hybrid CBT and self-help control 
intervention, (ii) assess recruitment strategies of practices, staff and patients, (iii) 
estimate attrition rates throughout the study, (iv) evaluate performance and 
acceptability of candidate outcome measures, and (v) evaluate the data collection 
method. Hence, in this article, we report the methods and findings from the 
feasibility trial, along with qualitative findings based on our process evaluation of 
patient experience.  
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Methods  
Patient and public involvement (PPI) 
Two patient representatives with prior training for research involvement were 
recruited for this study through the Warwick Universities/User Teaching and 
Research Action Partnership. Our PPI representatives were co-applicants of the 
grant application and members of the project management committee. They were 
involved in most aspects of the study including trial design, therapist training, trial 
implementation and results discussion. Additionally, a member of our research 
team with a chronic pain condition gave significant insights into the running of the 
trial on top of their technical research expertise.   
 
Trial setting and design 
The feasibility study was a randomised controlled trial with a multi-centre, 
parallel-group design situated within primary care. Treatments were offered to 
adults living with chronic pain and insomnia in the community and delivered by 
trained health psychologists at the primary care centre from which the patients 
were recruited. (ISRCTN registration number: 17294365) 
 
Participants were randomly assigned to receive one of two trial treatments for 
pain-related insomnia, in addition to treatment as usual (TAU). Here, TAU referred 
to the existing advice and prescribed medications for pain and insomnia that the 
participants were receiving. The assumption of TAU reflected the clinical reality 
that most patients with these chronic conditions would have already received 
some medical advice or treatment for their symptoms. 
 
Treatments 
Hybrid CBT  
The Hybrid CBT comprised select components of CBT-I and interventions 
designed to target cognitive-behavioural processes maintaining chronic pain. The 
core components of the treatment were described in Tang et al. (42) and included 
sleep psychoeducation, stimulus control therapy, sleep restriction therapy and 
cognitive therapy for addressing insomnia-related cognitions and behaviours 
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common amongst chronic pain patients. It also included individual formulation, 
goal setting and behavioural activation, components for reducing pain 
catastrophising and safety-seeking behavior, and reversing mental defeat for the 
management of chronic pain. The treatment was manualised for this study to 
facilitate therapist training; the guiding treatment principles were laid out in the 
treatment manual to support flexible treatment delivery for this patient group 
with complex needs.  
 
The format of the treatment can be described as ‘brief, intensive, and 
concentrated’ (44). Each patient allocated to the Hybrid CBT group was offered a 
total of four individual sessions on a weekly basis. Each session was 
approximately two hours long. The idea was to maintain the level of treatment 
content whilst minimising the burden of travel and duration of treatment, which 
may hinder treatment engagement in this patient group (45). 
 
Self-help control treatment  
Existing patient reading materials were amalgamated (with minimal 
modification) into four booklets to provide a self-help treatment on managing 
chronic pain and insomnia. The materials on insomnia were collated from the self-
help treatment developed by Morgan et al. (46) Compared to treatment as usual, 
the use of these self-help materials was found to be effective in improving 
insomnia symptoms in older adults attending primary care for sleep and other 
comorbid chronic conditions (post-treatment effect size on sleep measures 
ranged from d = 0.69 – 0.7) (46). The self-help booklets were posted to the 
patients’ homes, one at a time on a weekly basis. The content of the self-help gave 
equal coverage on chronic pain and insomnia management, approximating the 
structure and content of the Hybrid CBT. The self-help control treatment 
represented an active treatment control minus therapist contact.  
 
Therapists 
In the UK, clinical psychologists are not usually a part of the primary care medical 
team. Patients are often referred to see a psychologist for psychological 
interventions on an as-needed basis. Other provisions of care exist, e.g., in-house 
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counsellors and local Improving Access to Psychological Therapy (IAPT) teams, 
but availability of these services varies depending on locality and resource 
allocation. Previous trials of CBT-I in primary care have recruited nurse/health 
visitors for the delivery of treatment (47). Given the content (i.e., treatment of two 
complex health conditions), approach (non-protocol-based CBT), format 
(individual, brief but intensive) and focus (behaviour change) of the Hybrid CBT, 
health psychologists were chosen as therapists for this trial.   
 
Following targeted recruitment via health psychology training centres and 
professional networks across the UK, six health psychologists - fully qualified or 
in the latter stages of their stage II doctorate – were selected to receive three days 
of intensive training offered by the team. Three withdrew before the trial 
commenced due to clashes with existing employment/study commitments (e.g., 
maintaining private practice and completing other training) and the distance of 
travelling involved in the process of treatment delivery (e.g., from London or 
Staffordshire, where the recruited therapists were based, to Coventry, Rugby and 
Warwickshire, where the primary care centres were located). The remaining 
three (100% female) went on to become the trial’s therapists, which involved 
further training at their own pace via learning resources posted online, case 
piloting, regular individual supervision by experienced health psychologists on 
the team (HS, SP, NKYT), and travelling across sites to offer treatment to the 
patients in their localities.  
 
Patients 
We recruited 25 people living with chronic pain, between April 2016 and April 
2017 from three primary care centres in Coventry/Warwickshire of different 
demographic compositions (respectively having 2.1%, 3.7% and 25.8% non-white 
population) and different social-economic backgrounds (respectively scoring 1, 5 
and 8 on the 1-10 Index of Multiple Deprivation) (48).  
 
We identified participants for the study from the electronic registers held by the 
participating centres. Patients were initially screened by searching each centre’s 
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electronic patient records for inclusion criteria. We did two searches, with search 
terms broadened to include specific medications for the second search.  
 
Inclusion criteria were individuals (i) aged 18 years or above, (ii) English-
speaking, (iii) registered with one of the participating centres, (iv) with a history 
of chronic pain and insomnia (as indicated by their medical records), with (v) pain 
of at least moderate severity (>4/10 on a present pain intensity numerical rating 
scale for at least 6 months), and (vi) clinical insomnia (>15 on the Insomnia 
Severity Index, >3 nights a week, >1 month in duration). Criteria vi mapped onto 
the American Academy of Sleep Medicine Research Diagnostic Criteria for 
Insomnia Disorder (49), which is consistent with the DSM-5 diagnostic criteria 
although the latter adopted a three-month duration criteria (50). 
 
Participants taking pain/sleep medications on a stable regimen were included if 
they met criteria of the study. However, we excluded potential participants with 
diagnosed or suspected medical/psychiatric/sleep disorders for which CBT-I was 
contraindicated as first-line treatment or those who had recently enrolled in or 
were completing a pain management programme, or other psychological 
treatments for pain or sleep.  
 
As this was a feasibility study, no formal power calculation to test the effectiveness 
of the intervention was possible. The current sample size was determined by 
practicalities and considerations that it was sufficiently large to ensure that 
randomisation was acceptable and to buffer against atypical attrition.  
 
A randomisation list was created by the trial statistician (HP) using random blocks 
of varying sizes (block length=4 or 6). Blocks were generated in groups of patients 
at a 1:1 ratio, and stratified by centre from which the participants were recruited. 
Patients were randomised sequentially as they became eligible for inclusion in the 
study. Allocation was concealed using ‘e-envelopes’, which were macro-enabled 
MS Excel files preserved as read-only with automatic saving on any alteration to 
the file to give an audit log. This method was considered cost-efficient for a small-
scale feasibility study. Furthermore, the study statistician only released these e-
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envelopes and their passwords in small batches on request by the trial 
coordinator (CM). The study statistician had no contact with participants at any 
point in the study.  
 
Quantitative outcome measures  
We piloted the use of five validated questionnaires to collect data in this 
population. Our candidate primary outcomes were the Insomnia Severity Index 
(ISI) (51) and Brief Pain Inventory (BPI) pain interference subscale (52). 
Candidate secondary outcomes included the present pain intensity rating from the 
BPI (52), Multidimensional Fatigue Inventory (MFI) general fatigue score (53), 
Hospital Anxiety and Depression Scale (HAD) (54) and EuroQoL EQ-5D-5L (55), 
for which health utilities were calculated using the UK tariff of the EQ-5D-5L value 
set (56). The health thermometer score was also reported.  
 
Several process measures were included as part of the assessment to inform 
treatment and elucidate the role of hypothesised treatment mechanisms. These 
were the Pain Catastrophizing Scale (57), Pain Self-Perception Scale (58) Anxiety 
and Preoccupation about Sleep Questionnaire (59), Dysfunctional Belief and 
Attitude about Sleep Scale–16 (60), and Pain-specific Dysfunctional Belief and 
Attitude about Sleep Scale (61).  
 
In addition, the participants were asked to complete a daily sleep diary modified 
from the Consensus Sleep Diary (62) and to wear an actigraph (Model: MW8, 
supplied by CamNTech) for a week for baseline and 12-week follow up 
assessments to examine the feasibility of incorporating objective sleep measures 
for future trials. 
 
Statistical analysis  
As the aim of the current trial was to evaluate study feasibility, not treatment 
efficacy, no formal between-group analyses were planned. However, planned 
analyses consisted of the generation of descriptive statistics for all time points, 
across all participants as a group, and the Cronbach’s alpha of the candidate 
primary outcome measures to assess if internal consistency of these measures 
 13 
was adequate when administered in a chronic pain patient sample with a minor 
modification (i.e., the sleep item was removed from the BPI to avoid criterion 
contamination). The candidate primary outcome measures were also checked for 
correlation to establish if co-primary outcomes were needed for a definitive study. 
 
Qualitative participant interviews  
Face-to-face semi-structured interviews were conducted before and after the 
intervention to explore participants’ expectations of the intervention and their 
overall experience post-intervention. These interviews were carried out 
individually with a subgroup (20%) of participants enrolled in the trial by a 
Research Fellow who specialises in qualitative health service research but was not 
involved in the treatment design and delivery process (VPN). The interviewer had 
no prior contact with the interviewees. Seed questions used to prompt these 
conversations are shown in Box 1.  
 
Box 1. Seed questions used in the semi-structured interviews pre- and post-
intervention for both Hybrid CBT group and Self-help control group arms. 
 
A. Pre-intervention interview 
1. We are very interested in your journey. When did you first notice your pain-related sleep 
disturbance? 
2. Did you put it down to anything? 
3. Did you talk to anyone about it? 
4. What did you do to try to help? 
5. Does anything make it better or worse? 
6. Have you seen any health professionals or other practitioners? 
7. What do you think is going to happen in this study?  
8. What are you hoping to get from this study? 
 
B. Post-intervention interview 
1. How did you get on with the study? 
2. Did you get any benefit from the study (attending the sessions/receiving the booklets)? 
3. What worked for you? 
4. What did not work for you? 
5. Would you recommend this type of programme to other people? 
6. If we ran this programme in a larger study is there anything you would change? 
7. How did you get on with the paperwork? 
8. How did you find the process of being in a research study? 
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Timelines of the participant’s symptom and treatment journey were drawn during 
the interview and field notes were written immediately post interview to promote 
reflexivity. The interviews were held at the participant’s primary care centre, and 
lasted for about 60 minutes each. Interviews were audio-recorded on an 
encrypted digital device. Recordings were transcribed verbatim and anonymised. 
Data transcription was supported by another doctoral-level Research Fellow with 
experience in qualitative health care research but again not involved in the study 
design and treatment delivery process (VEJC). NVivo software was used for 
managing the data for analysis of the interview transcripts.  
 
Thematic analysis was performed on the transcripts by the CI (NKYT) following 
the six key processes recommended by Braun and Clarke (63); familiarisation 
with the data set, generating initial codes, searching for themes, reviewing themes, 
defining and naming themes, and report production. Codes and themes extracted 
were then reviewed by the interviewer (VPN) and a second experienced 
qualitative researcher on the team (DE) to check for accuracy.  Comments received 
were then used to revise the analysis. Themes were extracted with the awareness 
that questions asked in the pre-intervention interviews were different from the 
post-intervention interview, and hence the analysis avoided referring to any 
within-participant change across these interviews. Constant comparisons were 
applied when analysing the post-intervention interviews, contrasting the 
experience of the participants assigned to receive Hybrid CBT with those assigned 
to the Self-help control treatment.  
 
Results 
Search results 
The searches identified a total of 1,434 potentially eligible patients across the 
three primary care centres (9.8% of all records). After receiving an invitation to 
become part of the study, 85 patients responded and were invited to telephone 
(n=45) and then in-person (n=40) screening to be further assessed for eligibility. 
Of the 25 (55.6% of screened) participants who were found to be eligible, all were 
recruited into the study. This corresponded to a pick-up rate of 1.7 per 1000 
registered patients and a successful recruitment rate of 1.9 participants per 
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month, or 0.6 participants per centre per month. Figure 1 specified the number 
and reasons for exclusion at screening and subsequent stages.   
 
Baseline participant characteristics 
Table 1 summarises the socio-demographic details provided by the study 
participants at baseline (n=25). At the group level, 56% of the participants were 
female with an average age of 49 years and a mean BMI of 29. The majority of the 
participants were white (96%) and married or living as married (60%). Forty-four 
percent of the participants had secondary level education as their highest 
educational qualification. At the time of the study, 40% of the participants were in 
paid work whilst 60% were unemployed, retired or engaged in other forms of 
activity, with 36% receiving some form of social benefits.  
 
The mean reported duration of pain was 11 years. Most of the participants 
described their pain as “constant” and the median number of pain sites reported 
was 5, with lower back as the most commonly identified pain site, followed by 
neck, shoulders, joints, legs, knees, arms, upper back, head and abdomen. The 
baseline present pain intensity VAS was 6.1, pain interference score 6.6, and ISI 
18.9. Treatment adherence and attrition  
 
All 14 participants assigned to the Hybrid CBT group completed session 1, nine 
completed (64.3%) sessions 2, 3, and 4. Of the five participants who discontinued, 
four gave ‘poor’ health and one gave ‘lack of time’ as reasons for withdrawal 
(Figure 1). Those withdrawn were recruited from primary care centres with more 
severe deprivation indices.  For the self-help control group, all leaflets were mailed 
to the participants weekly, as per protocol. No further adherence data were 
collected.  At 12-week, six participants were successfully followed up in each arm; 
at 24-week five. This gave an overall participant retention rate of 48% at 12-week 
and 36% at 24-week.  
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Table 1. Participants characteristics as measured at baseline. 
 
Baseline variable All  
 
N=25 
Recruitment centre (n, %) Primary Care Centre 1  8 (32) 
Primary Care Centre 2  10 (40) 
Primary Care Centre 3  7 (28) 
Gender (n, %) Female 14 (56.0) 
Age: years (mean, SD) 49.3 (9.8) † 
BMI: kg/m2 (mean, SD) 29.3 (7.6) 
Ethnicity (n, %) White  24 (96) 
Relationship status (n, %) Cohabiting/ Married/Engaged 15 (60) 
Single/ Separating 10 (40) 
Education (n, %) No formal qualifications 8 (32) 
Secondary 11 (44) 
Degree/professional qualification 6 (24) 
Employment (n, %) Paid work 10 (40) 
Retired/medically retired 6 (24) 
Unemployed 5 (20) 
Other 4 (16) 
Receiving benefits? (n, %) Yes  9 (36) † 
How long have you had the pain (minimum, in years) (mean, sd) 11.0 (9.0) ‡ 
What the pain is like (n, %) Constant 20 (80) 
Recurrent 3 (12) 
Occasional 1 (4) 
Missing 1 (4) 
No. of painful places given (median, range) 5 (1 – 8) 
Where is the pain (n, %) Head 3 (12) 
Neck 17 (68) 
Shoulders 18 (68) 
Upper Back 6 (24) 
Lower back 18 (72) 
Arms 9 (36) 
Legs 15 (60) 
Knees 13 (52) 
Abdomen 2 (8) 
Joints 15 (60) 
Other 7 (28) 
Brief Pain Inventory (mean, sd) Current pain severity  6.1 (1.5) 
Current pain interference 6.6 (1.5) 
Insomnia Severity Index (mean, sd) Total score  20.1 (4.9) 
† 1 participant missing data. ‡ 3 participants missing data. 
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Table 2. Descriptive statistics of the candidate primary and secondary outcome measures, as well as process measures. 
 
 Baseline 12 weeks 24 weeks 
 All  
(n=25) 
No. of valid 
response (n, %) 
All 
(n=25) 
No. of valid 
response (n, %) 
All  
(n=25) 
No. of valid 
response (n, %) 
Primary outcomes 
ISI (mean, sd) 20.2 (4.7) 24 (96) 14.4 (10.3) 10 (40) 14.8 (11.8) 8 (32) 
BPI interference 6.1 (1.7) 24 (96) 4.9 (2.5) 12 (48) 4.7 (2.7) 8 (32) 
 
Secondary outcomes  
BPI - pain intensity 6.2 (1.6) 24 (96) 5.1 (2.4) 12 (48) 5.5 (2.6) 8 (32) 
MFI - general fatigue 16.3 (3.6) 24 (96) 13.8 (3.7) 12 (48) 14.9 (3.2) 8 (32) 
HAD - anxiety 9.7 (3.0) 24 (96) 6.7 (5.5) 12 (48) 8.9 (4.9) 8 (32) 
HAD - depression 8.4 (3.5) 24 (96) 7.3 (4.6) 12 (48) 7.8 (5.1) 8 (32) 
EQ-5D - health thermometer score 50 (17.5) 24 (96) 58.9 (15.2) 12 (48) 58.8 (23.0) 8 (32) 
EQ-5D - utility score 0.60 (0.19) 24 (96) 0.57 (0.29) 12 (48) 0.56 (0.33) 8 (32) 
 
Process measures 
PCS  - pain catastrophising 15.7 (9.2) 24 (96) 9.5 (8.5) 12 (48) 10 (8.6) 8 (32) 
PSPS - mental defeat 30.8 (23.6) 23 (92) 21.9 (27.3) 12 (48) 14.7 (21) 6 (24) 
APSQ - sleep anxiety  68 (21.7) 24 (96) 50.2 (32.4) 12 (48) 49.2 (37) 9 (36) 
DBAS - sleep beliefs 5.6 (2.1) 21 (84) 4.1 (2.9) 10 (40) 4.0 (3.3) 8 (32) 
PBAS –-pain-related sleep beliefs 7.1 (2.1) 21 (84) 5.1 (3.4) 12 (48) 5.0 (3.7) 9 (36) 
 
 
Notes. ISI = Insomnia Severity Index. BPI = Brief Pain Inventory. MFI = Multidimensional Fatigue Inventory. HAD = Hospital Anxiety and Depression Scale. EQ-5D = 
EuroQol EQ-5D-5L. PCS = Pain Catastrophizing Scale. PSPS = Pain Self Perception Scale. APSQ = Anxiety and Preoccupation about Sleep Questionnaire. DBAS = 
Dysfunctional Beliefs and Attitudes and Sleep scale. PBAS = Pain-related Dysfunctional Beliefs and Attitudes about Sleep scale.  
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Outcome measures 
Both primary outcome measures appeared to have excellent internal consistency. 
The Cronbach’s alpha for the cohort was 0.94 (95% CI 0.92-0.97) for the ISI and 
0.88 (95% CI 0.87-0.95) for the pain interference score. Even though the BPI| sleep 
item was dropped to avoid criterion contamination, there was a strong non-zero 
correlation between ISI and BPI interference score (r = 0.81, 95% CI 0.67-0.89).  
 
Descriptive statistics of all primary and secondary outcome measures, as well as 
process measures, by assessment time points, are shown in Table 2. No adverse 
events were reported in either allocation groups.  
 
Participant Interviews 
Five patients were interviewed; three were from the Hybrid CBT group and two were 
from the Self-help control group. All completed both pre- and post-intervention 
interviews, except one in the Hybrid CBT group who only completed the pre-intervention 
interview. 
 
Pre-intervention 
Discussions in the pre-intervention interviews gave rise to six interesting themes, 
capturing several prominent psychosocial characteristics of the participants enrolled in 
the feasibility study. These themes (presented in Table 3 with additional illustrative 
quotes) were concerned with the participants’ sense of identity, personal adversities, 
treatment experience and coping strategies, perceived pain-sleep relationship, 
satisfaction with current service, and treatment expectations.  
 
Pain changed who I am 
There was a sense of damaged identity shared across the five participants interviewed. 
They appeared to define themselves by their experience of pain and losses due to pain. 
Frequent comparisons were made of what life was in the past, with what life is now and 
what life should be like at a certain age. The way in which participants spoke of their 
struggle with pain carried a sense of mental defeat. 
 
“I’ve been suffering with sleep deprivation for many years…pain the same. … it 
destroyed everything really… life changed a hell of a lot, … it stole my life away.” 
(Patient C) 
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Table 3. A summary of findings from the pre-intervention interviews, with additional quotes and implications for future trial planning. 
 
Theme Additional example quotes and/or additional notes* (Patient code 
for example quotes e.g., Patient X) 
Implications for future trial planning 
 
Pain changed who I am 
        
“…you’re in pain the whole time… [you] can’t move and somebody’s got 
to help you out of bed, which really at 48 I shouldn’t be like that. … I feel 
I’m always going to be a person with pain...” (Patient D) 
 
“I like to think that I’m quite strong but equally I feel that…I’ve given up. 
I’m frustrated [because] I’m hurting. I can’t escape.” (Patient E)  
Patients’ damaged sense of identity - and the related 
psychological processes that feed into it - should be 
kept as  a core target of the hybrid treatment and 
measured for pre-post intervention changes. 
Pain and sleep did not occur in 
psychosocial vacuum 
      
* No one single quote could satisfactorily illustrate the complexity of the 
psychosocial contexts described by the participants, and without risks of 
revealing their identities.  
 
Example adversities cited included ill health, mental health problems, 
car or work accidents, assaults, relationship breakdown, problems 
experienced by dependents or close family members, being a carer, job 
redundancy/ unemployment, financial difficulties, homelessness, and 
bereavement. 
 
 
Whilst the current hybrid treatment has room to 
support flexible treatment delivery for patients with 
complex needs, more considerations should be given 
to the context in which the treatment is being 
delivered, as well as to practical support required to 
enable the most disadvantaged/burdened patients 
to access treatment. 
Participants were not 
treatment naïve 
 
           
 
 
 
  
“You just try to help yourself a little bit but, whether that’s a good or 
bad thing I don’t know.” (Patient A) 
 
“I’m trying to think myself healthy…I’ve tried …books … having your 
room right and spraying your pillow … all sorts of things…” (Patient D) 
 
“…there wasn’t nothing that I haven’t already seen or read or something 
before….” (Patient E) 
Self-help treatments may not be considered as a 
satisfactory treatment option by this non-treatment 
naïve clinical population.  
 
An active alternative treatment with therapist 
contact may be a more appropriate control 
intervention in future trials. 
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Pain was thought to be the 
primary cause of sleep 
problems 
 
       
 
 
 
 
 
 
“I’m not just gonna blame the pain…I’ve got a [teenage] son who’s 
causing … I’m not naïve to think that’s not a contributing factor [to 
sleep problems]… And I do stress … that’s just in my nature.” (Patient D) 
 
“[when] I wasn’t sleeping the pain seemed more unbearable… 
Unbearable, [because] I was tired… And I felt run down it just seemed 
worse I think…” (Patient E) 
 
If patients hold a rigid belief that sleep will never 
improve unless pain is resolved, it would be difficult 
to get their buy-in to the Hybrid CBT on offer. As 
such, these beliefs need to be addressed upfront in 
the information sheet or during recruitment, to 
improve treatment uptake and subsequent 
adherence. 
 
Participants were dissatisfied 
with the services available 
 
 
             
 “Most doctors these days don’t…give the time of day. They’ve got your 
prescription written out before you go in.” (Patient C) 
 
“[Interviewer: So have you talked to anybody about your pain and 
sleep?] Only my GP…And they sort of got painkillers. They don’t really 
like to give sleeping tablets anymore. Um... They advised over the 
counter ones...which work to an extent ….” (Patient B) 
 
“I don’t feel that this surgery offers a lot of [non-drug treatments]....it 
can give (medication), but obviously I’ve stopped taking all tablets now 
for five weeks and I can’t see if there’s a difference from taking tablets to 
the placebo effect of fear that at least by reaching for the tablet there 
was something to help me.” (Patient E) 
 
The issue of validation (or the lack thereof) is not 
unique to chronic pain patients, but highlights the 
importance for future trials to provide generic 
clinical skills training to the study therapists (health 
psychologists in the current study, or other suitably 
trained allied health care professionals with 
appropriate expertise in future trials). This will 
allow the provision of quality therapist contact, 
which is valued by our target patient group. 
Participants’ treatment 
expectations were high 
 
            
“…just to help control pain and sleeping…you can’t work miracles but it 
might be something that can help me…To be honest … I’m hoping … you 
might have the magic cure, you never know.” (Patient A) 
 
“A bit more sleep. More than anything. I find if I’m tired, … the pain 
seems worse or I’m just not able to cope with it as well…So my theory is 
if I can just get a bit more sleep I can perhaps cope better with the pain.” 
(Patient B) 
 
Proactive management of patients’ treatment 
expectations at the outset of treatment, or as early 
as the enrolment stage in future trials, may help 
minimise attrition and unnecessary demoralisation.  
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Pain and sleep did not occur in psychosocial vacuum 
The interviewees’ descriptions of their treatment journeys revealed that the issues of 
chronic pain and insomnia were embedded within a larger context of personal 
adversities. It was difficult to tell whether these were psychosocial triggers or 
consequences of chronic pain and insomnia. Specifics of these adversities revealed 
themselves at different places of the interviews, where details of personal lives were 
volunteered to situate the conversation. Adversities came not in isolation but in clusters 
as chronic pain and insomnia became increasingly more severe and disabling. Example 
adversities cited included ill health, mental health problems, car or work accidents, 
assaults, relationship breakdown, problems experienced by dependents or close family 
members, being a carer, job redundancy/unemployment, financial difficulties, 
homelessness, and bereavement. 
 
 
Participants were not treatment naïve 
Perhaps an artefact of self-selection bias in an RCT, all participants interviewed had tried 
to manage their pain and insomnia using a combination of drug and non-drug strategies, 
invariably with limited success. The self-helping spirit is a double-edge sword. If the right 
treatment is identified, it could facilitate engagement and maximise treatment gains. It 
could also drive people to take bold steps to keep pain and sleep problems under control, 
using strategies that are not necessarily recommended by current evidence-based 
guidelines, which may lead to dashed hope and further demoralisation. 
 
“…Now I try to keep [pain medication] in my system all the time so there’s always 
something there …rather than waiting for the pain to start and then taking [the 
medication]. [Interviewer: Right so have you done that on the advice of somebody or 
off your own back?] No just off my own back...” (Patient B) 
 
Pain was thought to be the primary cause to sleep problems 
All participants interviewed shared a strong belief that pain was a major cause of their 
sleep problems. However, there was the awareness that other factors might also play a 
role in aggravating the sleep problems and that not sleeping well could have a reciprocal 
effect on the pain.  
 
“ [It’s the pain that] keeps me awake…As soon as you have pain then 
wakes…Sometimes you can’t sleep because of the pain, and then you’re up all night, 
you get yourself angry with yourself…” (Patient C) 
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Participants were dissatisfied with the services available 
All participants interviewed have had much interaction with multiple health service 
providers. They were most frustrated when they felt they were not being listened to or 
misunderstood by their GPs. They were also not happy with a lack of effective treatment 
choices, noting a contradictory combination of a heavy reliance on drugs for pain control 
with a general reluctance to prescribe sleeping tablets for insomnia.  
 
“I kept going with all this pain problems and that, never get nowhere… Just felt as 
though it was all in my head, nobody would listen to me…” (Patient A) 
 
 
Participants’ treatment expectations were high  
All participants interviewed showed understanding that the interventions offered were 
not ‘magic cures’, but nonetheless had high expectations for the treatments, reflecting the 
constant tension between ideally what the patients want (“no pain” and “lots of sleep”) 
and realistically what can be offered by an intervention designed to optimise 
management of these problems. 
 
“Obviously it’s not going to be magical overnight but even if it could give me ideas if 
I’m in that position how I should be  reacting …. Well my future…hopefully I will have 
no pain … lots of sleep and no stress.” (Patient D) 
 
These themes, together, contextualised the feasibility study, offering finer insights into 
the life circumstances of those who actually signed up for pain-related insomnia 
treatment. 
 
Post-intervention 
Discussions in post-intervention interviews revealed aspects of the intervention liked and 
disliked by the two interviewees (as graphically summarised for the Hybrid CBT in Figure 
2). Analysis of these factors was carried out separately for the Hybrid CBT and the Self-
help control groups, to generate clear suggestions as to how each of these interventions 
could be tweaked and improved from the patient experience perspective.  
 
Hybrid CBT 
Besides “very good practical advice” on sleep, both interviewees who completed the 
Hybrid CBT appeared to most appreciate the intervention for giving them a new 
understanding of sleep as well as themselves. In particular, they seemed to like the fact 
that these new insights enabled them to improve their sleep patterns and to change the 
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way they think about and react to situations in life. Their success in improving sleep also 
appeared to have boosted their confidence in initiating changes in other areas of their 
lives; a spill-over therapeutic effect.  
 
"… You know, understanding how you sleep really... a lot better frame of mind now 
and a lot better myself you know what I mean? ...Because they’re slowly dispersing 
these worries are, and things like that, a lot to look forward to, and different things, 
more positive now… [It]changes the way you think a little bit and me talking to [the 
therapist] that I want to walk more and do more... It makes you think like… I can do 
something about it, I’ve done this, I’ve done um this sleep pattern and that…” (Patient 
A)  
"I'm remembering everything and I really liked the study ‘cause it helps me do things 
different… it’s all about retrain(ing) your brain to you know understand our sleep 
patterns and things we do in our life, what we do and it works it really really works…" 
(Patient C) 
 
Both participants interviewed were also very positive about the one-to-one, face-to-face 
interaction they had with the therapists. They felt that they were being listened to, and 
really appreciated the fact that the therapists went to the community to offer the 
intervention in their locality. They also felt that they managed to derive a greater 
understanding of the treatment materials because they could talk to someone and ask 
questions as they arose, compared to reading the information on their own. Further, they 
felt that being able to talk confidentially to someone knowledgeable about their 
symptoms and experience had allowed them to process difficult emotions that may or 
may not be directly linked to the experience chronic pain. 
 
 “…the one-to-one sessions are good... They are really good. Um I don’t know how it 
would work in a group.” (Patient C) 
 “…I think you understand it a bit more by talking [to] somebody” (Patient A) 
"… I’d go home have a good read about [the treatment materials], some of it I didn’t 
understand but then when I come back I’d ask… or she’d explain to me… write it down 
and show me that this is the way to do it... So I was learning a new skill… I don’t think 
I’d have took it so serious ... I don’t think I would’ve, just read a couple of leaflets and 
oh yeah and then popped it down the side, I wouldn’t have thought about it…" (Patient 
C) 
“And at least they could come to me and I didn’t have to get there. I wouldn’t have 
done that you see?... Cause it’s on your door step it’s a lot easier ... and you fit it in” 
(Patient A) 
 
Three issues of the Hybrid CBT required attention. First, although sleep monitoring was 
an essential component of the intervention, the participants interviewed found 
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completing the sleep diary tedious and possibly sleep-interfering as they felt obliged to 
clock their activities and remember everything they had done. Second, the participants 
found components of the sleep restriction and stimulus control therapy hard to follow. 
Although their sleep became more consolidated as a result of these treatment 
components, they did not particularly enjoy the experience and felt it was important to 
be able to personalise the intervention. Third, the participants struggled to apply the sleep 
restriction therapy during pain flare ups. Further adjustments to the pace and method of 
the therapy may be required considering that an increase in pain is a possible side effect 
during the initial stage of the sleep restriction therapy. Application of digital technology 
may also help reduce the burden of data collection. 
 
 “[The monitoring/diary] was a bit monotonous, but then they’re not going to know 
unless you write it down…" (Patient A) 
 
 “I didn’t like that side of it (the sleep restriction and stimulus control therapy) ‘cause 
I do like to stay in bed…" (Patient C) 
“…but then you can have a flare up and then you’re struggling…you know?”   (Patient 
A) 
 
"… I was following it all um you know we’ve come to like an agreement on timing to 
go to sleep and timing to get up…, but the problem is I’ve got a bad neck"…"It’s really 
sore and moving it sometimes I can’t move it ... Can’t go out, can’t drive, can’t do 
anything cause my necks playing me up, so it knocked my sleep pattern a bit out of 
proportion…” (Patient C) 
 
Self-help control 
The Self-help control intervention was chosen to represent what was the best treatment 
option available for patients with chronic pain and insomnia in primary care. However, 
few positives were said about the Self-help control intervention, except that the advice 
given was ’sound’ and ‘clear’. Whilst both participants interviewed felt that overall the 
intervention was helpful, they felt that they were not learning much new information and 
could not pinpoint any specifics as to why and how the intervention was helpful. Their 
memories of what was being discussed in the self-help booklets were also very vague. 
They felt that the information provided in the booklets overlapped with information 
available in existing self-help books or internet sources. They also indicated that they 
wanted more contacts with health care professionals rather than being left to their own 
devices.  
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 “Yeah the study itself is alright…”… “On the sleep [side], the things it gives are clear 
and can be helpful, but to me I already practiced those things anyway… but I’ve 
already read up on lots of things and done, so there wasn’t a lot there that was 
explaining that I could take away and thought I’ve absorbed something new.”” 
(Patient E)  
 “So something’s obviously helped along the way but I can’t put my finger on one exact 
thing.” "[Interviewer: is there anything, is there anyway we could improve it do you 
think?] In a way perhaps a bit more contact because obviously you have the initial 
study ... I saw you for that interview sort of in the middle ... And then now, but other 
than the booklets then you are just sort of left to it.... There’s no contact whatsoever.... 
So some contact would’ve been useful." (Patient B) 
 
Other feedback from participants assigned to both groups were concerned with the 
randomisation procedure, intervention format, and data collection method. On 
randomisation, the participants in the Self-help control group indicated that it “would 
have been nice to have a choice” whereas those in the Hybrid CBT group imagined that 
they “wouldn’t have bothered” with the treatment or would have benefited less had they 
been assigned to the Self-help control group. There was also an agreement from 
participants of both groups on the intensity of the treatment, with too much to read 
and/or report. Whilst they did not have an issue with automated data collection devices 
(i.e.,  actigraphy), they had found it difficult to complete the sleep diary and recommended 
that the paper work of the treatment/study to be reduced.  
 
Discussion  
Delivering a brief but intensive intervention for the self-management of chronic pain and 
insomnia in primary care has proved to be challenging. Important lessons were learnt 
with regard to the infrastructure and trial design required to achieve better patient 
recruitment, treatment delivery, intervention adherence, and patient retention.  
 
Were the patient identification and recruitment strategies viable?  
Two searches were conducted to identify potential participants from electronic records. 
The initial search that used diagnoses as search terms identified only 263 potential 
participants across the three participating centres despite the high prevalence rates of 
both health conditions (64-67). The unusually low return might be explained by the fact 
that physician records did not always list sleep or chronic pain as diagnoses. A second 
search using a broadened set of search terms (including medication prescribed) was more 
successful, identifying 1,434 potential participants (inclusive of the 263 previously 
identified). Of those who responded to the invitations and were invited to full screening; 
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nearly a third were randomised into the study (63%). Of those who were not randomised, 
approximately equal numbers were ineligible and declined to attend full screening. This 
indicates that once found, recruiting patients into the study may not be an issue for a 
larger study, but capturing interested patients in the first place would be a challenge. 
Whilst the current pick-up rate of 1.7 per 1000 patients was satisfactory, future trials 
should multiply the number of recruiting primary care centres to ensure that the 
recruitment target will be reached in a timely fashion.  
 
Previous research has found that patients with insomnia tend to trivialise their symptoms 
and did not seek treatment due to beliefs that one should be able to cope with insomnia 
alone (68). Despite the brief but intensive nature of the Hybrid CBT, four weekly sessions 
plus homework and data collection is a significant time commitment. Future trials should 
consider addressing these unhelpful beliefs during patient recruitment and incorporate 
an incentive system to motivate eligible participants to commit themselves to treatment. 
For example, a US trial of a six weekly 90-minutes group CBT for insomnia and pain 
among older adults with osteoarthritis offered a USD$2 cash incentive in the initial postal 
invitation (69). Participants in this study were paid volunteers. They received a USD$50 
incentive payment after completing the baseline assessment and attending the first class 
(69). Similarly, an ongoing nurse-led brief insomnia treatment trial in the UK reimburses 
all participants after each completed follow-up visit; £5 at baseline, £10 at 3-month, £15 
at 6-month, and £10 at 12-month (70). The current study offered the treatment for free 
but did not have the budget to incentivise enrolment and treatment attendance. 
 
What were the rates of attrition? 
Loss to follow up was high in this feasibility study, but return rates were generally higher 
in the Hybrid CBT group than the Self-help control group. Adherence to the Hybrid CBT 
appeared to be most vulnerable after session 1. Ill health was cited as the main reason for 
drop-out and incidentally, all patients withdrawn were recruited from centres with more 
severe deprivation indices. Those who managed to return to session two fully adhered to 
the rest of the treatment programme and appeared to report sizeable improvements 
across outcome measures. Future trials should seek to investigate whether any 
systematic attrition from the Hybrid CBT occurs following Session 1 compared to the 
control intervention, and if so, why? One size does not fit all; it would also be important 
for future trials to identify demographic, socio-economic, and clinical factors that predict 
treatment suitability, directly answering the ‘what works for whom’ question. 
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In addition to a dedicated budget for incentivising follow-up rates, practical support (e.g., 
travel reimbursement, appointment reminders, between-session technical support) may 
also be required to remove participation barriers and reduce attrition in future trials. 
Qualitative feedback from our participant interviews also indicates that streamlining the 
data collection with the help of digital technologies or the use of a more active control 
intervention with more patient contact may help buffer against attrition.  Although the 
Hybrid CBT was generally well received by treatment completers, it could be simplified 
in future trials to reduce patient burden. We note that the majority of the treatment drop-
outs coincided with the introduction of sleep restriction component of the therapy in 
session 1 and prior to their return to session 2, when they were expected to report on 
their progress. Considering that sleep restriction is the most difficult and counterintuitive 
component of the therapy to follow, future trials with additional support for commencing 
sleep restriction may achieve better adherence to the intervention.  
 
How satisfactory and acceptable were the outcome measures and data collection methods?  
Candidate outcome measures tested in the current trial appear to be psychometrically 
sound and have good face validity for the stated purpose of assessment. Both primary and 
secondary outcome measures showed changes in the direction anticipated for both arms 
of the trial over time. Care must, however, be taken when interpreting the positive 
responses that were reported due to biases associated with selective uptake and study 
attrition. We note that participants who remained in the study had lower levels of pain 
intensity at baseline than those who withdrew or were lost at the 12-week follow up (BPI 
severity: 5.9 v 6.4, not tested), although levels of pain interference and insomnia were 
more similar (BPI interference: 6.1 v 6.2, ISI: 20.3 v 20.1, not tested).  
 
The pattern of change in the outcome measures was approximated by those of the process 
measures that assessed the hypothesised maintaining factors of pain and insomnia 
targeted by the treatments. Future trials should consider conducting appropriately 
designed analyses to examine whether changes in these processes mediate treatment 
outcomes. The combined use of a sleep diary and actigraphy is an important part of the 
assessment and treatment process (not reported in detail here), but the implementation 
of this recommended monitoring procedure proved to be challenging for the participants 
of the current study. Potential solutions to improve monitoring adherence in future trials 
may involve reducing the length of the monitoring procedure, more personalised data 
collection training and support, and the installation of analysis software in participating 
centres to minimise human errors in data transfer.  
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Strengths and limitations of this study 
This was a small-scale feasibility study with a subgroup of participants being interviewed 
pre-post treatment for their experience participating in the trial. The specific aims were 
not focused on estimating treatment efficacy but on the implementation aspects of the 
running of the trial. We refrained from reporting the data by group or estimating effect 
sizes of treatment as the study was neither designed or powered to do so (71, 72) Bearing 
in mind the implementation issues discussed above, findings could be used to inform the 
design of any future definitive study but must be interpreted within its bounds of 
generalisability.  
 
Therapist contact and the treatment focus on understanding how sleep works were highly 
valued by our interviewees. The delivery of the Hybrid CBT at the patient’s doorstep was 
also positively received. Future trials should seek to maintain the quality of contact, 
although this will have to be supported by a robust health economic analysis that 
examines the cost-effectiveness of providing the Hybrid CBT in its current format as 
compared to in group settings or in the form of telemedicine or internet-based 
intervention.  
 
Whilst no adverse event was formally reported, qualitative feedback suggested that 
increased pain – especially in the initial treatment period - may be a possible side effect 
of the sleep restriction component of the treatment. Further investigations into the 
frequency, timing, and severity of this potential side effect are required to ensure patient 
safety and, potentially, promote treatment adherence.  
 
A previous meta-analysis has found the short-medium term outcomes of patients with 
comorbid or primary insomnia receiving bibliotherapeutic self-help were superior to 
those of waitlist control (73). Although self-help treatment is the best available non-
pharmacological treatment options in many primary care settings, the trial team should 
consider whether it is an acceptable control intervention to offer in future trials.  The 
post-treatment interviews revealed that our participants were not naive to self-help and 
appeared to be demoralised by the lack of therapist contact and fresh treatment content. 
Perhaps, a therapist-led educational intervention is a more fitting control for future trials 
evaluating the effectiveness of the Hybrid CBT in primary care.  
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Conclusion 
The Hybrid CBT has the potential to fill an unmet clinical need. Through our feasibility 
trial, a treatment protocol and a corresponding therapist training programme have been 
developed to make the delivery of this brief but intensive intervention in primary care 
possible. In its current form, the Hybrid CBT may work for subgroups of individuals who 
manage to adhere to the programme. Future trials could overcome the challenges 
highlighted in this feasibility study by broadening recruitment catchment, incorporating 
an incentive system to motivate treatment uptake, streamlining the treatment to make it 
even more primary care friendly, and simplifying the data collection procedure to make 
it easier for the patients to take part and provide data for evaluation.   
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Figure legends 
 
Figure 1. CONSORT flow diagram from screening (open boxes) to post-screening 
(filled boxes) processes in the study. 
 
Figure 2. A summary of themes from post-intervention interviews of Hybrid CBT 
participants, highlighting the positives and negatives of the current treatment 
approach and content.  
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Figure 1. CONSORT flow diagram from screening (open boxes) to post-screening (filled 
boxes) processes in the study. 
 
 
 
Figure 2. A summary of themes from post-intervention interviews of Hybrid CBT 
participants, highlighting the positives and negatives of the current treatment approach and 
content.  
 
Positives
•Primary care location
•Therapist contact; being listened to
•Confidence from sleep improvement  
•Understanding how sleep works
Negatives
•More pain initially after sleep 
restriction
•Sleep restriction & stimulus control 
therapies are hard
•Sleep monitoring is tedious
